Nuvectis Pharma (NVCT)
NASDAQ:NVCT
Want to see NVCT full AI Analyst Report?
Nuvectis Pharma (NVCT) Ownership Overview
42.55% Insiders
4.41% Mutual Funds
5.94% Other Institutional Investors
4.88% ETFs
42.22% Public Companies and
Individual Investors
The ownership structure of Nuvectis Pharma (NVCT) stock is a mix of institutional, retail, and individual investors. Approximately 15.23% of the company’s stock is owned by Institutional Investors, 42.55% is owned by Insiders, and 42.22% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Nov 06, 2025 | xxxxxxxxxxxxx | $28600 | |
Nov 06, 2025 | xxxxxxxxxxxxx | $75270 | |
Nov 06, 2025 | xxxxxxxxxxxxx | $64240 | |
Oct 29, 2025 | xxxxxxxxxxxxx | $957083 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,675,924 | Insider | 13.86% | 40,986,553 | |
| 3,245,897 | Insider | 12.24% | 36,191,752 | |
| 1,806,319 | Insider | 6.81% | 20,140,457 | |
| 1,793,068 | Insider | 6.76% | 19,992,708 | |
| 743,327 | Institution | 2.80% | 8,288,096 | |
| 649,574 | Institution | 2.45% | 7,242,750 | |
| 509,107 | Institution | 1.92% | 5,676,543 | |
| 200,118 | Insider | 0.75% | 2,231,316 | |
| 168,140 | Insider | 0.63% | 1,874,761 | |
| 161,562 | Institution | 0.61% | 1,801,416 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 649,574 | Institution | 2.45% | 7,242,750 | |
| 161,562 | Institution | 0.61% | 1,801,416 | |
| 153,437 | Institution | 0.58% | 1,710,823 | |
| 92,057 | Institution | 0.35% | 1,026,436 | |
| 44,022 | Institution | 0.17% | 490,845 | |
| 26,029 | Institution | 0.10% | 290,223 | |
| 12,103 | Institution | 0.05% | 134,948 | |
| 8,235 | Institution | 0.03% | 91,820 | |
| 5,000 | Institution | 0.02% | 55,750 | |
| 3,098 | Institution | 0.01% | 34,543 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 439,687 | Institution | 1.66% | 4,286,948 | |
| 347,980 | Institution | 1.31% | 3,879,977 | |
| 198,461 | Institution | 0.75% | 1,934,995 | |
| 125,280 | Institution | 0.47% | 1,396,872 | |
| 79,738 | Institution | 0.30% | 777,446 | |
| 40,273 | Institution | 0.15% | 449,044 | |
| 16,085 | Institution | 0.06% | 179,348 | |
| 14,481 | Institution | 0.05% | 141,190 | |
| 6,838 | Institution | 0.03% | 73,235 | |
| 1,623 | Institution | <0.01% | 15,824 |
FAQ
Who Owns Nuvectis Pharma (NVCT)?
According to the latest TipRanks data, approximately 5.94% of the company's stock is held by institutional investors, 42.55% is held by insiders, and 42.22% is held by retail investors.
What percentage of Nuvectis Pharma (NVCT) stock is held by institutional investors?
According to the latest TipRanks data, approximately 5.94% of Nuvectis Pharma (NVCT) stock is held by institutional investors.
What percentage of Nuvectis Pharma (NVCT) stock is held by retail investors?
According to the latest TipRanks data, approximately 42.22% of Nuvectis Pharma (NVCT) stock is held by retail investors.
Who owns the most shares of Nuvectis Pharma (NVCT)?
Ron Bentsur owns the most shares of Nuvectis Pharma (NVCT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.